Comparative effectiveness of Empagliflozin in reducing the burden of recurrent cardiovascular hospitalizations among older adults with diabetes in routine clinical care.

Rishi J Desai,Robert J Glynn,Brendan M Everett,Sebastian Schneeweiss,Deborah J Wexler,Lily G Bessette,Anouk Déruaz-Luyet,Ola Vedin,Kimberly Brodovicz,Elisabetta Patorno

American heart journal（2022）

引用 7|浏览12

暂无评分

摘要

Empagliflozin, compared to sitagliptin or to a lesser extent GLP1-RA, was associated with a reduction in the burden of total CV hospitalizations and HHF in older patients with T2D.

查看译文

关键词

Diabetes,cardiovascular events,empagliflozin,recurrent events

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要